Innovations

This technology relates to the transdermal treatment of diabetes. In particular, to a formulation for the transdermal delivery of the photoactive antidiabetic agent diosgenin that is encapsulated and protected by an oil-in-water nanoemulsion matrix for the treatment of type 11 diabetes Mellitus

The innovation is the rational combination of ezetimibe and curcumin for the treatment of colon cancer- which means one can apply a cancer therapeutic, orally. This would have significant value to the African population and solve key issues like the packaging and distribution of chemotherapeutic

Currently, the ARC have three commercial cultivars, Ratel, Steenbok and Tredou. Ratel consists of a medium growth period whereas Steenbok consists of a short growth period with good drought tolerance making it suitable for areas with a dry climate. Tredou is the newest addition to the ARC cultivar